(Q46548047)

English

One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis

scientific article published in June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

cognitive dysfunction

1 reference

based on heuristic

inferred from title

methylprednisolone

1 reference

based on heuristic

inferred from title

author name string

H Zéphir

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

J de Seze

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

K Dujardin

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

G Dubois

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

M Cabaret

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

S Bouillaguet

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

D Ferriby

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

T Stojkovic

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

P Vermersch

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

11

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

360-363

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI).

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1172SR

21 January 2018

Interferon beta therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1172SR

21 January 2018

Neuropsychologic status in multiple sclerosis after treatment with glatiramer

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1172SR

21 January 2018

Effect of interferon-beta-1b on cognitive functions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1172SR

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1172SR

21 January 2018

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1172SR

21 January 2018

The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up.

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1172SR

21 January 2018

Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1172SR

21 January 2018

Primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458505MS1172SR

21 January 2018

Identifiers

10.1191/1352458505MS1172SR

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15957521

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46548047&oldid=2117514228"